e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Clinical aspects of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis
F. S. Oymak, N. Tutar, H. Buyukoglan, M. Bilgin, S. Balkanli, E. Mavili, R. Demir, I. Gulmez (Kayseri, Turkey)
Source:
Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Session:
Clinical aspects of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
729
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. S. Oymak, N. Tutar, H. Buyukoglan, M. Bilgin, S. Balkanli, E. Mavili, R. Demir, I. Gulmez (Kayseri, Turkey). Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis. Eur Respir J 2009; 34: Suppl. 53, 729
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Clinical, functional and morphologic features in patients with pulmonary Langerhans‘ cell histiocytosis (nonsmokers and smokers)
Source: Annual Congress 2009 - Tobacco: from smoke to disease
Year: 2009
Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Pathological findings in histiocytosis X with pulmonary hypertension
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Analysis of the clinical and pathological features of 10 patients with pulmonary sclerosing hemangioma
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005
Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003
Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH)
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg.
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 219s
Year: 2001
Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Clinico-radiological diagnosis of atypical forms of pulmonary sarcoidosis
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept